Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
Pre-publication versions of this article are available by contacting email@example.com.
|11 Feb 2018||Submitted||Original manuscript|
|10 Aug 2018||Author responded||Author comments - Nikolas von Bubnoff|
|Resubmission - Version 2|
|10 Aug 2018||Submitted||Manuscript version 2|
|28 Oct 2018||Author responded||Author comments - Nikolas von Bubnoff|
|Resubmission - Version 3|
|28 Oct 2018||Submitted||Manuscript version 3|
|5 Nov 2018||Editorially accepted|
|19 Nov 2018||Article published||10.1186/s12885-018-5045-7|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.